Cytek BioSciences, Inc. (CTKB) News

Cytek BioSciences, Inc. (CTKB): $5.73

0.28 (+5.14%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Filter CTKB News Items

CTKB News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CTKB News Highlights

  • CTKB's 30 day story count now stands at 3.
  • Over the past 7 days, the trend for CTKB's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • DEC are the most mentioned tickers in articles about CTKB.

Latest CTKB News From Around the Web

Below are the latest news stories about CYTEK BIOSCIENCES INC that investors may wish to consider to help them evaluate CTKB as an investment opportunity.

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference

FREMONT, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. CEO Dr. Wenbin Jiang is scheduled to present and participate in a Q&A session on Thursday, January 11, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentatio

Yahoo | December 28, 2023

Insider Sell: Cytek Biosciences Inc's CTO Ming Yan Disposes of 20,000 Shares

Ming Yan, Chief Technology Officer of Cytek Biosciences Inc (NASDAQ:CTKB), sold 20,000 shares of the company on December 19, 2023, according to a recent SEC Filing.

Yahoo | December 22, 2023

Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry

New System Saves Time and Resources, Improves Efficiency and Accuracy Cytek Orion The new Cytek® Orion™ reagent cocktail preparation system simplifies and accelerates laboratory workflow, assures consistent experimental results, saves time and reduces the potential for errors. FREMONT, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the introduction of the Cytek Orion™ reagent cocktail preparation system

Yahoo | December 21, 2023

Insider Sell Alert: CTO Ming Yan Sells 20,000 Shares of Cytek Biosciences Inc (CTKB)

In the realm of stock market movements, insider trading activity is often a significant indicator for investors.

Yahoo | November 22, 2023

Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference

FREMONT, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 35th Annual Healthcare Conference in New York, New York. Cytek management is scheduled to participate in a fireside chat on Tuesday, November 28th at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “

Yahoo | November 14, 2023

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2023 Earnings Call Transcript

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good day and thank you for standing by. Welcome to the Cytek Biosciences Third Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker […]

Yahoo | November 12, 2023

Cytek Biosciences Inc (CTKB) Q3 2023 Earnings Report Summary

Organic Growth Amidst Macro Challenges; Full-Year Revenue Outlook Adjusted

Yahoo | November 9, 2023

Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’

BioTech Breakthrough Awards As the only cell sorter on the market that offers the unique ability to combine the advantages of Full Spectrum Profiling™ technology with high-performance cell sorting, the Cytek® Aurora™ CS system has been selected as the winner of the “Cell Sorting Product of the Year” award in the third annual BioTech Breakthrough Awards program. FREMONT, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, an

Yahoo | November 8, 2023

Cytek Biosciences Reports Third Quarter 2023 Financial Results

FREMONT, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Total revenue was $48.0 million, representing 19% growth over the third quarter of 2022 Total revenue on a non-GAAP constant currency basis was $47.7 millionOrganic revenue was $41.2 million, representing an increase of 2% compared t

Yahoo | November 7, 2023

Earnings Preview: Cytek Biosciences, Inc. (CTKB) Q3 Earnings Expected to Decline

Cytek Biosciences, Inc. (CTKB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | October 31, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!